Hedged Bet: An Unusual AIDS Vaccine Trial
- 12 August 2005
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 309 (5737) , 1003
- https://doi.org/10.1126/science.309.5737.1003
Abstract
No one has yet found an AIDS vaccine that can trigger effective antibodies against HIV's surface protein. So Merck has constructed a vaccine that abandons antibodies altogether, and the company is testing it in a fast-tracked study to determine whether it's worth pursuing the approach.Keywords
This publication has 0 references indexed in Scilit: